Composition for treating climacteric syndrome, preparation and quality control method thereof

Abstract

The invention discloses a pharmaceutical composition for treating women menopausal syndrome, a preparation method and a quality control method. The pharmaceutical composition of the invention is composed of pharmaceutical raw materials of glossy privet fruit, palmleaf raspberry fruit, south dodder seed, tuber fleeceflower root, cortex lycii radicis, ladybell root, dwarf lilyturf tuber, baical skullcap root, rehmannia root, white paeony root, red paeony, Chinese angelica, nacre and blackend swallowwort root; the preparation method is that: the pharmaceutical raw materials are selected, ground into fine powder, screened and evenly mixed; every 100g of powder is added by 42g of refining honey and appropriate amount of water, pill making and low-temperature drying are carried out, thus preparing the pharmaceutical composition. The preparation method adopts high performance liquid chromatography to carry out the content measurement on paeoniflorin. The pharmaceutical composition of the invention has good efficacy for treating women menopausal syndrome.

Description

Composition for treating climacteric syndrome and its preparation method and quality control method technical field The invention relates to a traditional Chinese medicine composition, a preparation method and a quality control method thereof, in particular to a traditional Chinese medicine composition for treating women's climacteric syndrome, a preparation method and a quality control method thereof. Background technique Women's climacteric syndrome refers to a series of symptoms caused by endocrine disorders and autonomic dysfunction in women before and after menopause, such as hot flashes, flushes, sweating, restlessness, depression, insomnia, and sometimes emotional abnormalities. , moody, crying and laughing for no reason, like a mentally ill person. Traditional Chinese medicine believes that the occurrence of this disease is due to the gradual decline of kidney qi in women at the age of seventy-seven, deficiency of Chong and Ren, lack of essence and blood, or depres...

AI Technical Summary

Problems solved by technology

However, some women cannot use estrogen replacement therapy due to various reasons, such as uterine fibroids. Patients with uterine fibroids who use estrogen may become cancer

Other western medicines that relieve menopausal symptoms will also have side effects on the patient's body and cannot be used for a long time

Images